About 33 states now require insurers to offer at least some Medigap coverage access to disabled Medicare enrollees under age 65, but many of those states have different rules for people under 65 with end-stage renal disease, according to a 2017 analysis developed by Stephen Weiss, a senior health policy analyst with Virginia's Joint Commission on Health Care. Weiss prepared the analysis because the Virginia state Senate was considering a Medigap access bill that could have helped new Medicare enrollees under 65 with disabilities, but without kidney failure. The Virginia bill ended up dying in committee. People with end-stage renal disease now have only limited access to Medicare Advantage plans. Section 17006 of the 21st Century Cures Act requires all Medicare Advantage plans to cover people with end-stage renal disease starting in 2021.
William Schiffbauer, a lawyer who helps insurers analyze legislation, says in written comments on H.R. 3 that Section 801 could also create other types of Medigap access rights. One subsection, for example, could permit a consumer who has been in a Medicare Advantage plan for a year or more to return to Original Medicare and Medigap coverage at any time, Schiffbauer says. Medicare Advantage plans use provider networks and care management efforts to try to hold down costs. Buying Original Medicare with Medigap coverage typically costs more but gives the enrollees more flexible access to care. A provision that makes it easy for Medicare Advantage enrollees to return to Original Medicare with Medigap coverage at any time could cause health claims costs problems for the Original Medicare program and Medigap issuers, because the Medicare Advantage plan enrollees interested in returning to the Original Medicare program might be enrollees with serious health problems, Schiffbauer writes. If the Section 801 Medigap provisions now in H.R. 3 take effect as written, without new support programs, those provisions "will have the effect of significantly increasing the premiums charged for current Medigap policyholders," Schiffbauer predicts in the written commentary.
Some House bills related to health have attracted strong bipartisan support. H.R. 3 is not one of those bills. House Democrats voted 228 for H.R. 3. Republicans voted 2-191 against the bill. Because of the lack of the support from House Republicans, the bill appears to have little chance of reaching the Senate floor in its current form. But Section 801 may start discussions that will end up shaping Medigap access provisions in other bills. In the mid-1990s, for example, members of Congress held many hearings and debates on "patient bill of rights" proposals. Twenty years later, the patient bill of rights proposals came to life as part of the Affordable Care Act package.
A copy of the 12:07 p.m. Dec. 9 version of H.R. 3 is available here. The MedPAC report that includes data on the cost of care for Medicare enrollees under age 65 is available here. —Read Tell Your Clients How Medicare Advantage Plans Are Changing, on ThinkAdvisor. — Connect with ThinkAdvisor Life/Health on Facebook and Twitter.
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Sponsored by Allianz Life Insurance Company of North America
Enhanced First-Year Fixed Rate: 10-Year Accumulation Example
Sponsored by Nitrogen
The State of Investor Sentiment Report: Investor Sentiment in Volatile Markets
Sponsored by Global Atlantic Financial Group
Using a RILA as an Alternative Asset Allocation for Fixed Income